{
    "2020-06-05": [
        [
            {
                "time": "",
                "original_text": "汇丰研究：调整药业股目标价 看好中生制药(1177.HK)",
                "features": {
                    "keywords": [
                        "汇丰研究",
                        "药业股",
                        "目标价",
                        "中生制药"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}